The Next Generation Central Lab

A client-centered ‘Next Generation Central Lab,’ is a central lab that offers clinical laboratory testing, biorepository, logistics, and data management services through complete automation and optimized alignment and connectivity between operation, project management, QA, business development, finance, and information systems. The overall goal is to focus on clients’ needs and the ultimate success of the clinical trial study.

Dr. Nan Zhang, VP of Global Central Lab Services at Frontage Laboratories Inc., will provide a valuable update on the changes and current challenges in the central lab space, as well as how the ‘Next Generation Central Lab’ can add value to clinical trial studies.

Nan Zhang MD PhD
VP, Global Central Lab Services
Frontage Laboratories, Inc

Dr. Nan Zhang is an Anatomic Pathology, Clinical Pathology, and Hematology Board-certified Pathologist with over 20 years of experience in Clinical Laboratory Medicine and Biomedical Research. She provides leadership and strategic direction to global central laboratories at Frontage Laboratories, Inc., and is responsible for global quality, patient safety, regulatory compliance, operational excellence, process improvement, and organizational structure.

Before joining Frontage, Dr. Zhang served as the Medical Director at ACM Global Laboratories, and Director of Hematology, Flow Cytometry, Advanced Coagulation, and Blood Bank at Rochester General Hospital. From 2018 to 2019, she served as the President at the Western New York Society of Pathologists.

Register free: http://www.appliedclinicaltrialsonline.com/act_w/next_gen